Earnings Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 4 | 4 |
Avg. Estimate | 0.96 | 1.26 | 3.99 | 4.52 |
Low Estimate | 0.96 | 1.26 | 3.96 | 4.4 |
High Estimate | 0.96 | 1.26 | 4.01 | 4.58 |
Year Ago EPS | 0.97 | 1.28 | 3.86 | 3.99 |
Revenue Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 6 | 6 |
Avg. Estimate | 9.43B | 10.79B | 39.73B | 42.33B |
Low Estimate | 9.37B | 10.73B | 39.49B | 41.63B |
High Estimate | 9.49B | 10.85B | 39.96B | 43.09B |
Year Ago Sales | 8.99B | 9.44B | 37.7B | 39.73B |
Sales Growth (year/est) | 4.90% | 14.20% | 5.40% | 6.50% |
Earnings History | 2023-06-29 | 2023-09-29 | 2023-12-30 | 2024-03-30 |
---|---|---|---|---|
EPS Est. | 0.87 | 1.14 | 0.76 | 0.91 |
EPS Actual | 0.97 | 1.28 | 0.72 | 1.09 |
Difference | 0.1 | 0.14 | -0.04 | 0.18 |
Surprise % | 11.50% | 12.30% | -5.30% | 19.80% |
EPS Trend | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.96 | 1.26 | 3.99 | 4.52 |
7 Days Ago | 0.94 | 1.28 | 3.96 | 4.49 |
30 Days Ago | 0 | 0 | 4.02 | 4.54 |
60 Days Ago | 0 | 0 | 4.02 | 4.54 |
90 Days Ago | 0 | 0 | 3.96 | 4.37 |
EPS Revisions | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | N/A | 1 | 1 |
Up Last 30 Days | 1 | N/A | 2 | 2 |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | 1 | N/A | N/A |
Growth Estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current Qtr. | -1.00% | N/A | N/A | N/A |
Next Qtr. | -1.60% | N/A | N/A | N/A |
Current Year | 3.40% | N/A | N/A | N/A |
Next Year | 13.30% | N/A | N/A | N/A |
Next 5 Years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 Years (per annum) | -0.77% | N/A | N/A | N/A |